2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Color Vision Defects: new trials by email Literature Review of Color Vision Defects trials Research Report on Color Vision Defects
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) AGTC-402 - Achromatopsia | Phase 1 / Phase 2 | Unknown | Beacon Therapeutics | 24 | 2017-08-03 | 2022-07-22 |
| Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial) rAAV2tYF-PR1.7-hCNGB3 - Achromatopsia | Phase 1 / Phase 2 | Unknown | Beacon Therapeutics | 32 | 2016-04-11 | 2022-07-22 |
Eye Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Vision Disorders (1)
Cone Dystrophy (2) · Eye Diseases, Hereditary (2) · Pathological Conditions, Signs and Symptoms (2) · Eye Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Vision Disorders (1)
United States (2) · Israel (1)
R24EY022023 (1)